Skip to main navigation

Who We Are
Our Portfolio
Pipeline
Media & Investors
- Media
- Investors
  - News Releases
  - Events
  - Financials
  - Governance
  - Stocks
  - Reports
  - Resources
Connect

We strive to put patients first and preserve their future possibilities

Investor Relations

Overview
News Releases
Events
Financials
Governance
Stock Info
Reports
Resources

Event Type Conference Presentation

Jun 13, 2024 11:00 AM EDT

ZUSDURI 12-Month Durability of Response Data Event

Listen to webcast

Upcoming events

Event Type Conference Presentation

May 19, 2026 10:30 AM EDT

HC Wainwright 4th Annual BioConnect Investor Conference

Listen to webcast

Location

New York, NY

Event Type Conference Presentation

May 26, 2026 10:30 AM EDT

TD Cowen 7th Annual Oncology Innovation Summit

Listen to webcast

Past events

Event Type Earnings Conference Call

Aug 11, 2022 10:00 AM EDT

UroGen Pharma Q2 2022 Earnings Call

Listen to Webcast

Event Type Conference Presentation

Jun 9, 2022 1:00 PM EDT

Jefferies Healthcare Conference

Listen to Webcast

Event Type Conference Presentation

May 25, 2022 11:00 AM EDT

H.C. Wainwright Global Investment Conference

Listen to Webcast

Event Type Earnings Conference Call

May 10, 2022 10:00 AM EDT

UroGen Pharma Q1 2022 Earnings Call

Listen to Webcast

Event Type Earnings Conference Call

Mar 21, 2022 10:00 AM EDT

UroGen Pharma Q4 2021 Earnings Call

Listen to Webcast

Event Type Conference Presentation

Mar 8, 2022 10:30 AM EST

Cowen 42nd Annual Healthcare Conference

Listen to Webcast

Event Type Conference Presentation

Jan 13, 2022 9:45 AM EST

40th Annual J.P. Morgan Healthcare Conference

Listen to Webcast

Event Type Conference Presentation

Jan 10, 2022 7:00 AM EST

H.C. Wainwright BIOCONNECT Virtual Conference

Listen to Webcast

Event Type Conference Presentation

Nov 18, 2021 8:00 AM GMT

Jefferies London Healthcare Conference

Listen to Webcast

Event Type Conference Presentation

Nov 17, 2021 9:20 AM EST

Stifel 2021 Virtual Healthcare Conference

Listen to Webcast

First
Previous
…
Page 4
Page 5
Current page 6
Page 7
Page 8
Next
Last

Presentations

Urogen Corporate Presentation – May 2026

New Horizons in Bladder Cancer: ZUSDURI Duration of Response Results from the ENVISION Study

New Horizons in Bladder Cancer: Insights from Top-Line Data of ATLAS & ENVISION Studies

Who We Are
Our Portfolio
Pipeline
Media
Investors

Privacy Policy
Patent Notice
Terms of Use
Funding Requests

Follow Us: Linkedin opens in new window Twitter opens in new window

Connect

JELMYTO^®, UroGen^®, and RTGel^® are registered trademarks of UroGen Pharma, Ltd. All other trademarks are the property of their respective owners.

US-UGN-00269 05/24